Angel Investing Guide: How It Works, From Equity to Check Sizes
What is angel investing? How angel rounds work, what equity angels receive through SAFEs, notes or priced rounds, and how check sizes are set.
By Yenvy Truong · Founder and Managing Member, The LSM Group

Key Takeaways
- Angel investing is the practice of individuals putting their own capital into early-stage private companies, usually before institutional venture funds get involved, in exchange for startup equity or a right to receive it later.
- Understanding what is angel investing in practice means understanding the instrument. Angels typically invest through a SAFE, a convertible note, or a priced equity round, and each one changes when the investor actually becomes a shareholder.
- Most angel rounds in the US are private placements under Regulation D, so participation is generally limited to accredited investors, and the company files a Form D notice with the SEC after the first sale.
- Ownership is diluted by later rounds and option pool expansions. Pro rata rights, where offered, let an investor buy into future rounds to offset some of that dilution.
- Check sizes are shaped by the round, the instrument, whether the investor goes direct or through a syndicate, and how much of their portfolio they can afford to hold in illiquid, high-risk positions for many years.
- Returns, if any, come from an exit such as an acquisition or IPO, and there is no reliable timeline. Many early-stage companies return less than the capital invested, or nothing at all.
Angel investing sits at the earliest point of a company's financing life, when there is often a founding team, a product in development, and limited operating history. Individuals who invest at this stage take on more uncertainty than almost any other investor in the company's future cap table, and they do it with their own money rather than a fund's. The LSM Group works with accredited investors who want to participate in early-stage healthcare, applied AI and life sciences companies, and the questions in this guide are the ones that come up most often in first conversations.
For readers asking what is angel investing at a working level, rather than as a definition, this angel investing guide explains the mechanics from start to finish: who can invest, how a round actually comes together, what equity an angel receives and when, how that ownership changes over time, how investors size their checks, and how an investment eventually ends. The personal side of getting started, such as confirming accreditation and planning a first portfolio, is a separate set of decisions, and the steps to become an angel investor are worth working through before committing capital to a first round. This is educational content, not legal, tax or investment advice.
What Is Angel Investing?

The simplest answer to what is angel investing is this: a private individual provides capital to a young company, usually at the pre-seed or seed stage, and receives startup equity or a contractual right to future equity in return. The term "angel" comes from early theatre financing, where wealthy patrons funded productions that might never earn a return. The modern version follows the same logic. The investor accepts a high chance of loss in exchange for exposure to a small number of companies that may grow substantially.
Three features separate angel investing from other forms of private investment:
- Personal capital. An angel writes checks from their own balance sheet. A venture capital firm invests money raised from outside investors in its fund and is paid fees and carried interest for managing it. That difference shapes how quickly each one decides and how much each one invests, and it explains most of the practical gap between angel investors and venture capitalists at the same stage.
- Stage. Angels typically invest before a company has meaningful revenue or a proven business model. The evidence available is usually the team, the problem being solved, early technical or clinical progress, and the size of the opportunity.
- Involvement. Many angels contribute more than money. Introductions to customers, hires, regulators, clinicians or later-stage investors can matter as much as the capital itself, particularly in regulated sectors.
Angel investing is legal and common in the US, but it is not lightly regulated. Startups raise angel money by selling securities, so every round has to be registered with the SEC or fit within an exemption from registration. That framework determines who can invest.
Who Can Participate: Accredited Status and Rule 506(b)
Most angel rounds are private placements under Regulation D. The two most common versions are Rule 506(b) and Rule 506(c). Under Rule 506(b), the company cannot use general solicitation, meaning it cannot publicly advertise the offering, and it may sell to an unlimited number of accredited investors plus up to 35 non-accredited investors who have enough financial knowledge and experience to evaluate the investment. In practice, most early-stage companies sell only to accredited investors, because adding non-accredited purchasers triggers detailed disclosure obligations, including financial statement information.
The accredited investor definition sits in Rule 501(a). For individuals, the main routes are:
- Net worth over $1 million, alone or with a spouse or spousal equivalent, excluding the value of a primary residence.
- Income over $200,000 in each of the two most recent years, or $300,000 jointly with a spouse or spousal equivalent, with a reasonable expectation of reaching the same level in the current year.
- Holding a Series 7, Series 65 or Series 82 license in good standing.
The company files a notice on Form D with the SEC within 15 days after the first sale of securities in the offering. Form D describes the offering, not individual investors, and investors do not file anything themselves. What investors do sign is a subscription agreement, usually with an accredited investor questionnaire attached, confirming that they meet one of the qualifying tests.
How Does Angel Investing Work, Step by Step

People asking how does angel investing work are usually trying to picture the sequence from first meeting to signed documents. The details vary by company and by group, but most rounds follow the same broad path.
1. Sourcing
Angels see companies through personal networks, founder referrals, angel groups, syndicates and accelerator programs. Because Rule 506(b) offerings cannot be publicly advertised, most early-stage rounds circulate through relationships rather than open marketing. This is one reason angels with a strong network in a particular sector tend to see more relevant opportunities in that sector.
2. Screening
The first filter is usually fit. An investor or group asks whether the company sits in a sector they understand, whether the stage matches their approach, and whether the founding team has the background to execute. Many investors decline far more companies than they back at this step, often after a single conversation or a review of the pitch deck.
3. Due Diligence
Diligence at the angel stage is lighter than at later stages because there is less history to examine, but it still matters. Typical areas include:
- Team. Founder backgrounds, relevant experience, commitment, and how equity is split among founders, including vesting.
- Market and problem. Who pays, how the product fits existing workflows, and what the realistic path to adoption looks like.
- Technology or science. Whether the core claim holds up. In healthcare and life sciences, this often means assessing clinical evidence, regulatory pathway and reimbursement, which is where domain expertise changes the quality of the review.
- Cap table and prior financing. Who already owns what, any outstanding SAFEs or convertible notes, and how they will convert.
- Legal basics. Incorporation, intellectual property assignment from founders, and any material agreements.
Sector focus helps here. An investor who concentrates on a defined investment thesis, such as healthcare, applied AI and life sciences, can compare each company against a deeper base of knowledge than one who invests across unrelated industries.
4. Terms
The company and its lead investor, if there is one, agree on the instrument and its key terms: valuation or valuation cap, any discount, investor rights, and the total amount being raised. For a priced round, this is usually captured first in a short term sheet that is mostly non-binding. For a SAFE or convertible note, the terms are often standard enough that the company simply circulates the documents.
5. Closing
Investors sign the investment documents and subscription agreement, complete the accredited investor questionnaire, and wire funds. Rounds frequently close in stages, with some investors signing earlier than others. After the first sale, the company files its Form D and any state notice filings that apply.
6. After the Investment
Once the money is in, the relationship shifts to monitoring and support. Investors may receive periodic updates, attend investor calls, or help with introductions. Information rights, where they exist, set out what the company must share and how often.
Do Angel Investors Get Equity?
A common question is do angel investors get equity, and the short answer is yes, but not always immediately. The instrument used in the round determines whether the angel becomes a shareholder at closing or holds a right to shares that converts later.
Priced Equity Rounds
In a priced round, the company and investors agree on a valuation, and investors buy shares at a fixed price per share. At the angel and seed stage, these are typically preferred shares, often labelled Series Seed preferred. Preferred stock usually carries rights that common stock held by founders and employees does not, including:
- Liquidation preference. On a sale or wind-down, preferred holders are generally paid back their investment, or a multiple of it, before common holders receive anything. Early-stage rounds commonly use a 1x non-participating preference, meaning the investor receives either their money back or their share of the proceeds as if converted to common, whichever is greater.
- Protective provisions. Certain major decisions, such as issuing a new senior class of stock or selling the company, may require approval from a majority of the preferred holders.
- Information rights. A right to receive financial statements or updates, sometimes limited to investors above a set size.
- Pro rata rights. A right to invest in future rounds to maintain the investor's percentage ownership.
Priced rounds require more legal work and negotiation, so they are less common at the very earliest stage than the two instruments below.
SAFEs
A SAFE, or Simple Agreement for Future Equity, is a contract that gives the investor the right to receive shares in a future priced round. It is not debt. A standard SAFE has no interest rate and no maturity date. Until it converts, the SAFE holder is not a shareholder and typically has no voting rights.
The two terms that matter most are the valuation cap and the discount. The cap sets the maximum valuation at which the SAFE converts, and the discount gives the SAFE holder a lower share price than new investors in the priced round. When both apply, the investor usually converts at whichever produces more shares. Many SAFEs now in use are post-money SAFEs, which make it easier for both founders and investors to calculate the ownership the SAFE will represent at conversion. If the company is acquired before any priced round, the SAFE typically entitles the holder to either their money back or the amount they would receive on conversion, whichever is greater, subject to available proceeds.
Convertible Notes
A convertible note is a loan that is designed to convert into shares rather than be repaid. It usually carries a modest interest rate, which accrues and converts along with the principal, and a maturity date by which the note must convert, be repaid or be extended. Like a SAFE, a note often includes a valuation cap and a discount. Because it is debt, a note technically gives the investor creditor rights at maturity, although in practice noteholders rarely force repayment from an early-stage company and usually agree to extend.
How the Three Instruments Compare
| Feature | Priced Equity | SAFE | Convertible Note |
|---|---|---|---|
| Investor becomes a shareholder at closing | Yes | No, converts later | No, converts later |
| Valuation set at closing | Yes | No, cap and discount instead | No, cap and discount instead |
| Interest | None | None | Usually accrues |
| Maturity date | None | None | Yes |
| Legal cost and complexity | Highest | Lowest | Moderate |
| Typical investor rights | Defined in financing documents | Limited until conversion | Limited until conversion |
All three end in the same place if the company raises a priced round: the investor holds equity. The difference is timing, price and the rights attached along the way.
How Ownership Changes After the Investment
An angel's percentage of startup equity is rarely static. Each new financing round issues new shares, and each expansion of the employee option pool does the same. Both dilute existing holders.
A simple hypothetical shows the effect. Suppose an investor holds 1% of a company after its seed round. The company then raises a larger round that issues new shares equal to 20% of the company after the round. The investor's stake falls to 0.8%. If the next round issues another 20%, the stake falls to 0.64%, before any option pool increase. Dilution is not automatically a loss. If each new round is priced higher than the last, the smaller percentage can be worth more than the original larger one. It becomes a problem when a company raises at a flat or lower valuation, or when later investors negotiate senior rights that move ahead of earlier ones.
Pro rata rights are the main tool angels use to manage this. They allow the investor to buy enough of the next round to hold their percentage steady, although exercising them requires new capital each time. Many angels set aside reserves for follow-on investments for this reason. Others choose to exercise pro rata only in companies that are clearly progressing, which concentrates later capital where the evidence is strongest.
Healthcare · AI · Life Sciences
Access to Healthcare's Best De-Risked Deal Flow
Every deal is validated by domain experts before capital moves. See how the syndication model works.
Check Sizes: How Angels Decide How Much to Invest
There is no standard angel check size. The amount an investor puts into a single company is shaped by several factors, most of which have little to do with the company itself.
The round and the instrument. Founders set a target raise and decide how many investors they want on the cap table. Some rounds set minimum investment amounts to keep the cap table manageable. Investors in a priced round may also be offered a specific allocation by the lead.
Direct investing versus a syndicate. An angel who invests directly negotiates their own allocation and appears individually on the cap table. An angel who participates through an investment syndicate invests through a special purpose vehicle that pools several investors into a single line on the cap table. This often allows smaller individual commitments than a company would accept directly, and it moves diligence, document negotiation and administration onto the syndicate lead.
Portfolio construction. Early-stage outcomes are uneven. A small number of companies tend to produce most of a portfolio's gains, and many return little or nothing. Because no investor can reliably predict which companies will be the outliers, experienced angels generally favour spreading capital across a larger number of companies over concentrating it in a few. That approach pushes individual check sizes down for a given total allocation.
Total allocation to early-stage companies. The starting point is usually how much of an investor's overall portfolio they are prepared to hold in illiquid, high-risk positions that may not return capital for many years, or at all. That figure, divided across the number of companies the investor wants to back over several years, sets a practical range for each check.
Reserves. If the investor intends to exercise pro rata rights, part of the total allocation needs to be held back for follow-on rounds. Investors who skip reserves can back more companies initially but will see their ownership diluted in the ones that succeed.
Pacing. Spreading investments across several years, rather than deploying everything at once, reduces the risk of concentrating a portfolio in a single market cycle.
How Do Angel Investors Work With the Companies They Back
Searches for how do angel investors work often reflect a question about the relationship after the check clears. Involvement ranges widely. Some angels are passive and simply receive updates. Others act as informal advisers, help recruit early hires, open doors to customers or partners, or prepare founders for the next round.
In healthcare, involvement is often most valuable where the investor has direct domain knowledge. Clinicians understand how a product will fit into care delivery, how purchasing decisions are made inside a hospital or practice, and where regulatory or reimbursement risk is likely to sit. That perspective is one reason many physicians choose to invest at this stage, and why The LSM Group built a dedicated network for physicians investing in healthcare, AI and life sciences companies.
Angels rarely take board seats at the earliest stage. When they do, the seat usually goes to a lead investor who has put in a meaningful share of the round. More commonly, angels hold no formal governance role and influence the company through the founders' willingness to seek their advice.
How Angel Investments End: Exits, Timelines and Liquidity
Angel investments are illiquid. Startup equity acquired in a private round consists of restricted securities that cannot be freely resold, and there is usually no market for them. Capital typically comes back only through one of the following events:
- Acquisition. Another company buys the startup. Proceeds flow through the liquidation preference stack, with preferred holders paid according to their rights before common holders.
- IPO. The company lists its shares publicly. After any lock-up period and applicable resale restrictions, investors can sell in the public market.
- Secondary sale. An investor sells their shares to another buyer before an exit, sometimes through a company-organized tender offer. These opportunities are uncommon at early stages and are often subject to company approval and rights of first refusal.
- Write-off. The company shuts down or is sold for less than the preference stack, and the investor recovers little or nothing.
There is no dependable timeline. Companies that reach an exit commonly do so many years after the first angel round, and a single company can raise several more rounds before that happens. Investors should assume their capital will be locked up for an extended period with no option to withdraw it.
Tax Points Every Angel Investor Should Understand
Two provisions of the Internal Revenue Code are especially relevant to angel investing in US companies structured as C corporations. Both have detailed eligibility conditions that should be reviewed with a tax adviser.
Qualified Small Business Stock. Under Section 1202, gain on qualifying stock acquired at original issuance from a qualified small business can be partially or fully excluded from federal income tax. The One Big Beautiful Bill Act, enacted on July 4, 2025, changed the rules for stock acquired after that date. The exclusion is now tiered: 50% after three years, 75% after four years and 100% after five years. The per-issuer cap on excludable gain rose from $10 million to $15 million, and the gross asset ceiling for a qualifying company rose from $50 million to $75 million. Stock acquired before the enactment date remains under the earlier rules, which generally require a holding period of more than five years. Because a SAFE or convertible note is not stock until it converts, when the holding period begins for these instruments is a technical question that investors should raise with their advisers.
Ordinary loss treatment under Section 1244. Losses on qualifying small business stock issued directly to an individual can be treated as ordinary losses rather than capital losses, up to $50,000 per year, or $100,000 on a joint return. The company must have received no more than $1 million in total capital for its stock at the time the shares were issued, and the stock must have been issued for money or other property.
Investors who participate through a syndicate or special purpose vehicle usually receive a Schedule K-1 rather than holding shares directly, which affects how gains and losses are reported, and the eligibility rules for these provisions apply differently to stock held through a partnership.
Key Risks to Weigh Before Investing
Angel investing carries risks that are different in kind, not just degree, from public market investing:
- Loss of capital. Many early-stage companies fail or are sold for less than the capital they raised. A full loss on an individual investment is a normal outcome, not an exception.
- Illiquidity. Capital may be committed for many years with no way to sell.
- Dilution and seniority. Later rounds can reduce ownership and introduce rights that rank ahead of earlier investors.
- Information gaps. Private companies are not required to provide the disclosure that public companies do. Investors depend on what the company chooses to share and what their own rights require.
- Concentration. A portfolio with only a few companies is highly exposed to the outcome of each one.
These are structural features of the asset class rather than problems that can be solved with better selection. Careful diligence, sector knowledge and diversification can help an investor make better-informed decisions, but none of them removes the possibility of loss.
Next Steps
Anyone who has followed this angel investing guide from the definition through to exits will have noticed that the answer to what is angel investing depends heavily on structure. It rewards preparation: knowing how each instrument works, what rights come with it, how ownership is likely to change, and how to size commitments within a broader portfolio. For accredited investors interested in early-stage healthcare, applied AI and life sciences, The LSM Group runs a syndication model that is open to accredited investors, and joining is free. Each company goes through domain expert review before it is presented to members.
The process starts with a short questionnaire, followed by a 10-15 minute call with Yenvy to talk through your background and goals. Membership follows that conversation. To request a conversation or ask a question first, email hello@thelsmgroup.com.
Frequently asked questions
What Is Angel Investing?
Angel investing is when a private individual invests their own money in an early-stage company, usually at the pre-seed or seed stage, in exchange for equity or a right to future equity. Angels typically invest before institutional venture capital funds and often contribute advice and introductions as well as capital.
How Does Angel Investing Work?
A company raising an early round shares its plans with potential investors, who screen the opportunity, carry out due diligence and agree on terms. Investors then sign the investment documents and a subscription agreement, confirm their accredited status and fund their commitment. The company files a Form D notice with the SEC after the first sale.
Do Angel Investors Get Equity?
Yes, though not always at closing. In a priced round, angels receive shares, usually preferred stock, immediately. With a SAFE or convertible note, the investor holds a right to shares that converts into equity at a later priced round, typically at a price set by a valuation cap or discount.
How Do Angel Investors Work With Startups After Investing?
It depends on the investor. Some are passive and receive periodic updates. Others advise founders, make introductions to customers, hires or later-stage investors, and help prepare for the next round. Board seats at the angel stage are uncommon and usually reserved for a lead investor.
What Is the Difference Between a SAFE and a Priced Round?
In a priced round, the company sets a valuation and investors buy shares at a fixed price with defined rights. A SAFE defers the valuation. The investor receives shares later, when the company raises a priced round, at a price determined by the SAFE's valuation cap or discount.
How Long Does It Take to See a Return From Angel Investing?
There is no reliable timeline. Returns depend on an exit such as an acquisition or IPO, and companies that reach one often do so many years after the first angel round. Many angel investments never produce a return, so investors should expect capital to be locked up for an extended period.